Can a gentler mouthwash win kids over without sacrificing gum health?
NCT ID NCT07662226
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a hyaluronic acid mouthwash is more acceptable to children than a standard chlorhexidine mouthwash, while still controlling plaque-induced gingivitis. Thirty-two children aged 8 to 12 with signs of gingivitis will use one of the two mouthwashes. Researchers will measure taste acceptance using a faces scale and track gum health with standard dental indices. The goal is to find a mouthwash that children will actually use, improving their oral hygiene habits.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Hyaluronic acid mouthwash (Q-Afta®) and chlorhexidine 0.12% mouthwash (Hexitol®)
- What this could lead to
- If hyaluronic acid mouthwash tastes better and works as well as chlorhexidine, it could improve children's willingness to use mouthwash regularly, helping control gingivitis.
- What could go wrong
- This is a small, early-phase trial with only 32 children, so results may not apply to all kids. Hyaluronic acid may not be as effective as chlorhexidine at reducing plaque or gum inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1
The first testing in people. Mainly checks safety and dose, usually in a small group.
- Participants
-
About 32 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
8 to 10 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged from 8-12 years of both sexes. * Children with a history of bleeding on brushing typical signs and symptoms of gingivitis. * Healthy child (ASA I). * Eruption of upper and lower permanent central and lateral incisors. * Parent's agreement to sign the informed consent. * Parent's ability for attending follow up visits. Exclusion Criteria: * Children -allergic to Chlorhexidine or Hyaluronic acid. * Children with special health care needs or having a history of serious systemic disease that may affect the gingival health. * Use of Systemic NSAIDs, steroids, or antibiotics within a month before the study. * Children undergoing orthodontic treatment or having an intra-oral prosthesis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Plaque induced gingival disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Faculty of dentistry, Cairo university
Cairo, Egypt, 11411, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.